Details on upcoming events are not yet available.

View our Archived Events and Presentations

In The News

Tricking the Virus with a Protein Could Prevent Covid-19
ARA. December 12, 2020

Animal Tests Reveal Synthetic Decoy Protein Protects Against Coronavirus
Chemistry World. Dec. 7, 2020

Antibodies Good. Machine-Made Molecules Better?
The New York Times. Nov. 21, 2020

How One Company Pivoted From Cancer To Coronavirs And Designed A Virus-Blocking Drug In 10 Weeks Nov. 19, 2020

Scientists Advance on One of Technology’s Holy Grails
The New Yorker. Sept. 18, 2020

Neoleukin emerges with a de novo approach to improving biologics
BioCentury – Emerging Company Profile, July 18 2019

If you build it, they will come: Reaching across the “IL” with Neo-2/15
ScienceImmunology, March 1, 2019

Neoleukin-2/15 – A Novel Immunotherapy Agent Designed to Avoid Common Side Effects
OncoZine, Jan. 16, 2019

Neoleukin Therapeutics Hopes to Improve on Nature's Approach to Battling Cancer
BioSpace, Jan. 11, 2019

Scientists design protein that prods cancer-fighting T-cells
University of Washington Medicine Newsroom, Jan. 10, 2019

New Protein Designed that Mimics IL-2 without Severe Side Effects
Genetic Engineering & Biotechnology News, Jan. 10, 2019

Researchers redesign a cancer-busting protein—without the side effects
Science, Jan. 9, 2019

New Seattle startup emerges from UW to develop cancer-fighting protein three decades in the making
GeekWire, Jan. 9, 2019

MEDIA Contact